Jukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at:
|
|
- Janel Palmer
- 6 years ago
- Views:
Transcription
1 Hospital to Retail Spillover Analysis and Its Impact on Commercial Decision Making Jukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at: 1
2 Disclaimer The information provided and opinions expressed by the presenter and set forth in the following slides are those of the individual presenter and should not be attributed to Pfizer Inc., any of its affiliates, or any of its or their directors, officers, or employees, nor any other organization with which the presenter may be affiliated. Unless specifically stated otherwise, examples and views provided herein, including strategies, goals, targets, and indicators, are for illustrative purposes only and should not be regarded as representative of Pfizer or its portfolio. Content in this presentation is the intellectual property of the individual presenter and subject to protection under the copyright laws of the United States of America and other countries.
3 Life Sciences Commercial Data Insights Presentation Objective In this presentation, we discuss how multiple large data sources and complex analytics can be used to derive actionable insights to help commercial groups in large pharmaceutical companies Datasets Analytics Decision Support Activity Prescriptions HCP to Hospital Mapping Zip Code to Hospital Mapping Other data Trend, Correlation, Regression Field Force Sizing Samples to Patient HCP and Patient Communication 3
4 Life Sciences Commercial Data Insights (continued) Presentation Objective Our focus is on better understanding the resource allocation needs for therapeutic areas where treatment often starts in hospitals but is maintained outside in retail HCP offices. Disease Diagnosis and Initial Treatment vs. Hospital MD s Office 4
5 Life Sciences Commercial Data Insights (continued) Presentation Objective Resource allocation needs may be related to the number of field representatives who provide information on disease states, clinical studies and medicines to health care providers. Reps also hold speaker programs where physicians, often from academic institutions, have discussions with their peers on best ways to treat patients. Resource allocation needs may also be related to drug samples that are given to HCPs who in turn provide these to patients who can try out the best medicine for long-term treatment, patient assistance programs or patient education brochures. 5
6 Agenda Introduction to Hospital to Retail Spillover Physician Spillover Patient Spillover Importance of Measurement of Hospital to Retail Spillover Use of Multiple Large Data Sources to Synthesize Insights Data Sources to Measure Physician Spillover Data Sources to Measure Patient Spillover Other Data Sources Results and Implication 6
7 Agenda Introduction to Hospital to Retail Spillover Physician Spillover Patient Spillover Importance of Measurement of Hospital to Retail Spillover Use of Multiple Large Data Sources to Synthesize Insights Data Sources to Measure Physician Spillover Data Sources to Measure Patient Spillover Other Data Sources Results and Implication 7
8 Hospital to retail spillover occurs in two main ways Intro to Spillover Hospital and Its Neighborhood Dynamics of Hospital Spillover Direction of Spillover Sales within Hospitals Rx s from HCPs who work in hospitals and also own practices or have colleagues who work in hospitals + Patients from far away may decide to get treated in a hospital because of its reputation and continue post treatment with HCPs in own localities ) Physician Spillover Patient Spillover 8
9 Spillover area of a hospital could vary depending on its reputation overall or within a therapeutic area University Hospital in a Large NE City No. Zip Codes Serviced: 1,000+ Total Cases: ~20,000 Total Days of Care: 100,000+ Intro to Spillover Source: Publicly Available Database 9
10 Spillover area of a hospital could vary depending on its reputation overall or within a therapeutic area University Hospital in the South No. Zip Codes Serviced: ~100 Total Cases: ~2,500 Total Days of Care: ~15,000 Intro to Spillover Source: Publicly Available Database 10
11 Hospital to retail spillover emerges from the fact that a therapy initiated in a hospital tends to be maintained by the community physician Spillover varies by therapeutic area Intro to Spillover Initial diagnosis and treatment in hospital Continuation of therapy by community physician Change in therapy after admission Lifestyle related therapies: Mostly initiated in HCP offices Chronic conditions and co-morbidities: Mainly initiated in HCP offices, but a patient could get admitted into a hospital for other comorbidities and diagnosed with diabetes; maintenance through ARBs, OADs and insulins Acute, event driven conditions or therapies: Most starts in hospitals when patient gets admitted, with maintenance through beta-blockers and statins by office based HCPs Pfizer Confidential 11 11
12 Patients who get started on a drug in the hospital (or retail) setting tend to stay on it for a length of time, as captured by adherence and persistency metrics 90% Persistency Rates for Brands Intro to Spillover % Persistency 70% 50% 30% A C B D 10% Month from patient s start Product Patient life time RX value A 20 B 15 C 10 D 5 Numbers presented here are for illustrative purpose only Pfizer Confidential 12 12
13 Agenda Introduction to Hospital to Retail Spillover Physician Spillover Patient Spillover Importance of Measurement of Hospital to Retail Spillover Use of Multiple Large Data Sources to Synthesize Insights Data Sources to Measure Physician Spillover Data Sources to Measure Patient Spillover Other Data Sources Results and Implication 13
14 An understanding of hospital to retail spillover may have an impact on the resource allocation decision Importance of Spillover Estimation of the magnitude of hospital-retail spillover is important to commercial teams in making resource allocation decisions Retail Field Force Size No Spillover Consideration 500 Spillover Consideration 400 Hospital Field Force Size Numbers presented here are for illustrative purpose only 14
15 An understanding of the hospital to retail spillover may have an impact on hospital segmentation Importance of Spillover Hospital segmentation may need to be updated if hospital to retail spillover is incorporated into decision making. For example, hospitals with larger footprint may need more reps to hold discussions with HCPs on disease states and available treatment. No Spillover Consideration Hospital Segment Resources Spillover Consideration Hospital Segment Resources Changes to segmentation and annual call activity Numbers presented here are for illustrative purpose only 15
16 An understanding of the hospital to retail spillover may have an impact on patient assistance and affordability programs Impact on the Pricing Decision Importance of Spillover No Spillover Consideration Spillover Consideration Hospital that gets discounted pricing Hospital that gets regular pricing Numbers presented here are for illustrative purpose only 16
17 Agenda Introduction to Hospital to Retail Spillover Physician Spillover Patient Spillover Importance of Measurement of Hospital to Retail Spillover Use of Multiple Large Data Sources to Synthesize Insights Data Sources to Measure Physician Spillover Data Sources to Measure Patient Spillover Other Data Sources Results and Implication 17
18 Multiple large data sets are used to derive insights through complex analytics Data Sources Drug Usage and Purchase 1 Rx Data at HCP Level Drug Purchase Data at Hospital Level 2 HCP Spillover (HCP to Hospital Linking Data) 3 4 Affiliation Data (External) Affiliation Data (Internal) Patient Spillover (Hospital to Zip Code Linking Data) 5 Health Atlas Data (Publicly Available) Additional Data to Optimize Resources 6 Internal Activity and Resources Data Response analysis Optimization modeling Usage by Indication 7 Survey Audits or Anonymized Patient Level Data with ICD-9 Codes 18
19 Databases that link HCPs to hospitals are used to assess physician component of the spillover Databases that Link HCPs to Hospitals Data Sources Corporate Parent Corporation / Integrated Systems Organization to organization relationship Provider Facilities Healthcare Facility Healthcare Professionals Prescription Activity MD, NP, RN, PA. TRx Organization to healthcare provider relationship Source: Internal and External Data Sources Pfizer Confidential 19 19
20 Databases that link HCPs to hospitals can be maintained internally at a manufacturer or be available from external sources Data Sources Fields in a Typical HCP to Institution Mapping Database HCP ID Facility ID Facility Name Facility Address Facility City Facility State Facility Zip Facility Type Parent Company ID Parent Company Name Parent Company Address Parent Company State Parent Company Zip Parent Company Type Source: Internal and External Data Sources Examples and views herein are for illustrative purposes and should not be regarded as representative of Pfizer or its Pfizer portfolio. Confidential 20 20
21 Databases that link treatment zip codes to hospitals are used to measure patient component of the spillover Data Sources Typically used to study variations in distribution and usage of medical resources in national, regional, and local markets Used by policymakers and health care analysts to study health care system Forms the foundation for many efforts to improve health and health systems Examples of publicly available research that uses Health Atlas Data Health Care Spending, Quality and Outcomes (2009) Prices Don t Drive Regional Medical Spending Variations (2010) The Elusive Connection Between Health Care Spending and Quality (2010) Our Parents, Ourselves: Health care for an Aging population (2016) The Revolving Door: A Report on US Healthcare Admissions (2014) Source: Publicly Available Data Sources Pfizer Confidential 21 21
22 Databases that link patient treatment zip codes to hospitals are used to measure patient component of the spillover Data Sources Fields in a Database that Links Patients to Hospitals Hospital ID Count Of Zip Codes of Residence Total Days of Care Total Cases A ,000 10,000 B ,000 3,000 C ,000 5,000 D 70 7,000 1,000 E 70 2,000 1,000 F 100 7,000 1,000 G ,000 3,000 H ,000 7,000 I ,000 2,000 J 25 1, K ,000 4,000 L M ,000 3,000 N 80 5,000 1,000 Source: Publicly Available Data Sources 22
23 Example Research: Regional Variation in Use of Beta Blockers After Heart Attack Use of beta blockers within first six months following hospitalization for heart attack ( ) Data Sources Source: The Dartmouth Atlas of Medicare Prescription Drug Use, The Dartmouth Institute for Health Policy and Clinical Practice, 2013; Accessed on 10/1/2016 Pfizer Confidential 23 23
24 Anonymized patient level data used to calculate factors for multiple indications for a drug Anonymized patient level databases typically run into hundreds of millions of rows Such databases generally have several components Data Sources Diagnosis Data Includes ICD-9 (or ICD-10) codes that can be used to identify disease conditions like diabetes, high blood pressure, arrhythmia, etc. Prescription Data Includes names of drugs, both generic and branded When filled Units, form and strength HCP id Zip code of patient Eligibility Information Indicates if the anonymized patient level data has been captured continuously Provider Data HCP ID and specialty, etc. Payer Data Name and address Source: External Data Sources Examples and views herein are for illustrative purposes and should not be regarded as representative of Pfizer or its Pfizer portfolio. Confidential 24 24
25 Agenda Introduction to Hospital to Retail Spillover Physician Spillover Patient Spillover Importance of Measurement of Hospital to Retail Spillover Use of Multiple Large Data Sources to Synthesize Insights Data Sources to Measure Physician Spillover Data Sources to Measure Patient Spillover Other Data Sources Results and Implication 25
26 Hospital to retail spillover could vary considerably from one therapeutic area to the next Quantifying Hospital Influence on a Therapeutic Area Results and Implications Hospital sales (Non-retail) Direct Sales Low spillover for lifestyle related therapies Medium spillover for chronic conditions or co-morbidities High spillover for acute, event driven conditions and therapies Sales to HCPs who work in hospitals, but are affiliated to hospitals (Retail) Physician Spillover Nonspillover Patient Spillover Sales due to influence on patients from distant localities 26
27 Field force sizing decision may be revisited with the hospital level spillover sales data Broad Range of Sales Drivers Results and Implications Driver 1 Sales Data Data at level of individual hospitals Hospital + Retail Spillover months of data Mixed regression model (PROC MIXED in SAS) Driver 4 27
28 Optimization may demonstrate a need to change field force size Results and Implications Optimization using response curves and economic principle of marginal revenue equals marginal cost at the optimal point 28
29 Results and Implications Field force resources may need to be increased to promote to hospitals for therapeutic areas with large spillover Therapeutic Area with Significant Spillover Retail FF Size No Spillover Consideration 500 Spillover Consideration 400 Hospital FF Size Numbers presented here are for illustrative purpose only 29
30 Data for four US hospitals show that those with larger foot print may more resources to optimally provide support to HCPs and their patients need 30
31 Summary Hospital to retail spillover varies by therapeutic area. For chronic disease states where therapy frequently begins at hospitals, but is maintained outside by community HCPs, spillover could be significant. Both physician and patient spillover components are important. Resource allocation decisions may be impacted by spillover. For example, hospitals with a large spillover may need more reps to provide optimal support to HCPs and their patients. 31
We see health care. differently. Comprehensive data Novel insights Transformative actions Lasting value
We see health care differently Comprehensive data Novel insights Transformative actions Lasting value 24 Hours of Optum data: Creating a more complete health picture We capture: Largest EHR dataset 90
More informationLEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017
LEERINK GLOBAL HEALTHCARE CONFERENCE Marino Garcia EVP, Chief Strategy Officer February 15, 2017 SAFE HARBOR STATEMENT This presentation and any statements made for and during any presentation or meeting
More informationNovartis: tackling adherence. ESPACOMP, September, 2010
Novartis: tackling adherence ESPACOMP, September, 2010 Novartis is a world-leading healthcare company Leading market position One of 20 largest companies by market capitalization Among most respected companies
More informationValue of Hospice Benefit to Medicaid Programs
One Pennsylvania Plaza, 38 th Floor New York, NY 10119 Tel 212-279-7166 Fax 212-629-5657 www.milliman.com Value of Hospice Benefit May 2, 2003 Milliman USA, Inc. New York, NY Kate Fitch, RN, MEd, MA Bruce
More informationThe Economic Burden of Hypercholesterolaemia
The Economic Burden of Hypercholesterolaemia November 2018 TABLE OF CONTENTS Acronyms 3 Executive Summary 4 Introduction 5 Approach 5 Structure of the report 5 Economic burden of hypercholesterolaemia
More informationThis is a licensed product of Ken Research and should not be copied
1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market
More informationBoehringer Ingelheim Pharmaceuticals, Inc. & Univision. Making Diabetic Hispanics Healthier
Boehringer Ingelheim Pharmaceuticals, Inc. & Univision Making Diabetic Hispanics Healthier Agenda BIPI and the Hispanic segment Organizing and Executing to Win The Proof is in the Results Making Hispanics
More informationBig Data & Predictive Analytics Case Studies: Applying data science to human data Big-Data.AI Summit
Big Data & Predictive Analytics Case Studies: Applying data science to human data 1.03.2018 Big-Data.AI Summit Dr. Arnim Jost, Commercial Director Technology Copyright 2017 IQVIA. All rights reserved.
More informationUnderstanding the Value of Generic Drugs
Understanding the Value of Generic Drugs Generic drugs can help you get the most out of your health care budget. 05.02.306.1 (8/05) Many people believe that when something costs more, it must be of higher
More informationJefferies Healthcare Conference June 6, 2018
Jefferies Healthcare Conference June 6, 2018 Forward-Looking Statements Some of the statements included in this presentation, particularly those regarding the commercialization and ongoing clinical development
More informationSocial Determinants of Health
FORECAST HEALTH WHITE PAPER SERIES Social Determinants of Health And Predictive Modeling SOHAYLA PRUITT Director Product Management Health systems must devise new ways to adapt to an aggressively changing
More information4Q and Full Year 2017 Financial Results Call February 7, 2018
4Q and Full Year 2017 Financial Results Call February 7, 2018 Agenda Topic Welcome Opening Remarks 4Q 2017 Results Commercial Progress Question & Answer Speakers Amy Sullivan, SVP, Corporate Affairs Greg
More informationWalgreens (WAG) Analyst: Juan Fabres Fall 2014
Recommendation: Buy Target Price August 31, 2016: $77.57 1. Reasons for the Recommendation With the acquisition of Alliance Boots in Europe, Walgreens will be the first US pharmacy to operate retail stores
More informationREFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) Executive Summary Table below provides a summary of the key metrics for Cariprazine in the seven major pharmaceutical
More informationREFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) Executive Summary Clozaril: Key Metrics in the Seven Major Pharmaceutical Markets, 2012 2022 2012 Market Sales US 5EU
More informationGlobal Standard Radiography Film X-Ray Film Printer Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Standard Radiography Film X-Ray Film Printer Market Research Report 2016 Global Standard Radiography Film
More informationGlobal Oil Softgel Capsules Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Oil Softgel Capsules Market Research Report 2016 Global Oil Softgel Capsules Market Research Report 2016
More informationGlobal Vitamin Market Professional Survey Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Vitamin Market Professional Survey Report 2016 Global Vitamin Market Professional Survey Report 2016 Publication
More informationREFERENCE CODE GDHC109PIDR PUBLICAT ION DATE MAY 2015 FIBROMYALGIA GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC109PIDR PUBLICAT ION DATE MAY 2015 FIBROMYALGIA GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2023 Executive Summary Fibromyalgia: Key Metrics in Seven Major Pharmaceutical Markets, 2013
More informationImproving Type 2 Diabetes Therapy Compliance and Persistence in Brazil
July 2016 Improving Type 2 Diabetes Therapy Compliance and Persistence in Brazil Appendix PATIENT ACTIVATION Introduction This Appendix document provides supporting material for the report entitled Improving
More informationSuccesses in Regional Collaboration to Achieve the Triple Aim Oregon. Pay for Performance Summit San Francisco March 24, 2014
Successes in Regional Collaboration to Achieve the Triple Aim Oregon Pay for Performance Summit San Francisco March 24, 2014 Agenda Oregon Health Care Quality Corporation (Q Corp) Background Priority Projects
More informationGlobal Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016 Global Magnetic Resonance Imaging (MRI)
More informationChronic Care. Coloplast Capital Market Day Jan Rolin Frederiksen, President Coloplast US. Coloplast Capital Market Day 2009
Coloplast Capital Market Day 2009 Jan Rolin Frederiksen, President Coloplast US Page 1 Agenda Product Portfolio Ostomy Care Continence Care Wound and Skin Care Page 2 Portfolio covers four product-business
More informationREFERENCE CODE GDHCER046 PUBLICAT ION DATE OCTOBER 2013 DIABETIC FOOT ULCERS - EPIDEMIOLOGY FORECAST TO 2022
REFERENCE CODE GDHCER046 PUBLICAT ION DATE OCTOBER 2013 DIABETIC FOOT ULCERS - Executive Summary Diabetic foot ulcers (DFUs) are a major complication of diabetes that occurs as a result of trauma to or
More informationSanofi Press Breakfast on Behavioral Science. Friday 22 September 2017
Sanofi Press Breakfast on Behavioral Science Friday 22 September 2017 Agenda WHY UNDERSTANDING BEHAVIORS CAN UNLOCK CARE SUCCESS 8.45-9.00 Welcome coffee 9.00 Kick-off 9.00-9.10 Introduction by Alexandra
More informationSo, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International
So, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International 1 Disclaimer The views and opinions expressed in the following PowerPoint slides are
More informationSession 304: How to Integrate Palliative Care Into Your Community-based Home Health and Hospice Programs
Session 304: How to Integrate Palliative Care Into Your Community-based Home Health and Hospice Programs Bob Parker, RN, MSN, CENP, CHPN Corporate Director of Palliative Care Interim Healthcare Objectives
More informationDOES PROCESS QUALITY OF INPATIENT CARE MATTER IN POTENTIALLY PREVENTABLE READMISSION RATES?
DOES PROCESS QUALITY OF INPATIENT CARE MATTER IN POTENTIALLY PREVENTABLE READMISSION RATES? A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Jae Young Choi,
More informationImproving Type-2 Diabetes Therapy Adherence and Persistence in Turkey
November 2017 Improving Type-2 Diabetes Therapy Adherence and Persistence in Turkey How to Address Avoidable Economic and Societal Burden PATIENT ACTIVATION Introduction This Appendix document provides
More informationREFERENCE CODE GDHC1062CFR PUBLICATION DATE JUNE 2013 CHRONIC HEART FAILURE - JAPAN DRUG FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC1062CFR PUBLICATION DATE JUNE 2013 CHRONIC HEART FAILURE - JAPAN DRUG Executive Summary Sales for Chronic Heart Failure in the Japan The Japan Chronic heart failure (CHF) therapeutics
More informationBRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationThe Diabetes Community Sentinel Project
The Diabetes Community Sentinel Project About the National Minority Quality Forum A DC-based, research and education organization that publishes the National Health Index (NHI) The NHI a comprehensive
More informationEU5 Bariatric Surgery Procedures Outlook to 2020
EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationTamper-Resistant Properties of Drugs Regulations (TRPDR)
Tamper-Resistant Properties of Drugs Regulations (TRPDR) Cost Impact Analysis, 2019 PMPRB presentation to federal, provincial, and territorial public plan representatives on September 29, 2015. 1 Patented
More informationMembership Guidelines
Our Network with Results International ( NWRI ) membership guidelines are recommended practices that allow our chapters to run efficiently and effectively for everyone involved. Business networking is
More informationApplying Six Sigma Principles to Drive Healthcare Behavior Change:
Applying Six Sigma Principles to Drive Healthcare Behavior Change: Using Medication Compliance to Improve Healthcare Outcomes Presented by: Todd Prewitt, Director of Clinical Operations/Medical Director,
More informationNATIONAL HEALTH POLICY FORUM
NATIONAL HEALTH POLICY FORUM UTILIZATION PATTERNS IN ADVANCED IMAGING: THE RADIOLOGY BENEFIT MANAGEMENT EXPERIENCE Susan Nedza, MD, MBA, FACEP Chief Medical Officer AIM Specialty Health / WellPoint, Inc.
More informationThree Rules for Measuring Physician Market Share
Crimson Market Advantage RESEARCH BRIEFING Three Rules for Measuring Physician Market Share Research and insights Performance Technologies Consulting and management Talent Development new definition Hospitals
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationElsevier ClinicalKey TM FAQs
Elsevier ClinicalKey FAQs Table of Contents What is ClinicalKey? Where can I access ClinicalKey? What medical specialties are covered in ClinicalKey? What information is available through ClinicalKey?
More informationREFERENCE CODE GDHC361DFR PUBLICAT ION DATE FEBRUARY 2014 INVEGA (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC361DFR PUBLICAT ION DATE FEBRUARY 2014 INVEGA (SCHIZOPHRENIA) Executive Summary Invega : Key Metrics in the Seven Major Pharmaceutical Markets, 2012 2022 2012 Market Sales US 5EU Japan
More informationREFERENCE CODE GDHC356DFR PUBLICAT ION DATE FEBRUARY 2014 SAPHRIS (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC356DFR PUBLICAT ION DATE FEBRUARY 2014 SAPHRIS (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSISTO 2022 Executive Summary Saphris: Key Metrics in the Seven Major Pharmaceutical Markets, 2012
More informationYour Partnership in Health Report: Chronic Conditions ABC Company and Kaiser Permanente
Your Partnership in Health Report: s ABC Company and Kaiser Permanente Measurement Period: JUL-01-2012 through JUN-30-2013 Report Date: DEC-31-2013 Commercial All Members Partnership in Health (PIH) reports:
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationHave you been paying for your prescription drugs? Stop!
Dear Valued Medtipster Member: Have you been paying for your prescription drugs? Stop! Free prescription drugs are NOW just a Medtipster ID card away. Follow the steps below to obtain thousands of generic
More informationJefferies Healthcare Conference. June 2016
Jefferies Healthcare Conference June 2016 Today s Speakers John Figueroa Chief Executive Officer Vic Breed Chief Financial Officer Joined Genoa in July 2014 Previously served the dual roles of CEO of Apria
More informationPrescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study
Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois
More informationGLOBAL INSIGHT SERIES. Global Baking Insights: Gluten-Free Bread Consumption
Global Baking Insights: Gluten-Free Bread Consumption Gluten-Free bread is moving mainstream, creating huge innovation opportunities for bakeries The baking industry has experienced significant change
More informationImproving Mental Health Care: A Case Study
Improving Mental Health Care: A Case Study Why Improve Mental Health Care? Because the prevalence and costs of mental health problems are increasing in America despite the high prescribing of psychotropic
More informationHEART FAILURE QUALITY IMPROVEMENT. American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement
HEART FAILURE QUALITY IMPROVEMENT American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement 1 DISCLOSURES NONE 2 3 WHY IS THIS IMPORTANT? WHY? Heart Failure Currently, an
More informationThe Economics of Smoking
The Economics of Smoking One of the potential problems (from an economic perspective) with smoking is that there may be an externality in consumption, so there may be difference between the private and
More informationSAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
More informationDIGITAL DIABETES CARE MARKET READY TO TAKE OFF
DIGITAL DIABETES CARE MARKET 2018-2022 READY TO TAKE OFF www.research2guidance.com A market study about diabetes apps, connected devices, and services 3 rd edition, 3 rd September 2018 Research2Guidance
More informationCOMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS
COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS Community Oncology Alliance 2 Physician Ratings Consumers want information about quality Have become used to
More informationSegment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
More informationWALGREENS & RITE AID MERGER ANALYSIS
WALGREENS & RITE AID MERGER ANALYSIS FOR MORE INFORMATION: CALKAIN COMPANIES Hamza Rashid Research Analyst T: 703.787.4714 E: research@calkain.com @ calkain WALGREENS + RITE AID This report examines the
More informationMarket Distortions from the 340B Drug Pricing Program
Market Distortions from the 340B Drug Pricing Program Adam J. Fein, Ph.D. www.drugchannels.net @DrugChannels The opinions and views expressed in this presentation are those of the author and may not reflect
More informationNET LEASE PORTFOLIO INVESTMENT OPPORTUNITY
NET LEASE PORTFOLIO INVESTMENT OPPORTUNITY Walgreens Portfolio Three Properties Knoxville, TN Port Orchard, WA Cincinnati, OH Available on an Individual or Portfolio Basis DISCLAIMER STATEMENT DISCLAIMER
More informationImproving Type 2 Diabetes Therapy Adherence and Persistence in the United States
July 2016 Improving Type 2 Diabetes Therapy Adherence and Persistence in the United States Appendix PATIENT ACTIVATION Introduction This Appendix document provides supporting material for the report entitled
More informationGlobal Patient Scales Market Research Report 2021
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Patient Scales Market Research Report 2021 Global Patient Scales Market Research Report 2021 Publication
More informationAsia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3
More informationGlobal Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast ( )
Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast (2017-2022) Analysis By Type - Fresh/Dried leaves, Stevia powder,
More informationGlobal HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )
Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) By Region- North America, Europe, APAC and RoW By Country - United
More informationTHE COST DRIVERS OF CANCER CARE
THE COST DRIVERS OF CANCER CARE Debra Patt, MD, MPH, MBA David Eagle, MD Ted Okon, MBA Don Sharpe 20156Community Oncology Alliance 1 Welcome & Introductions Debra Patt, MD, MPH, MBA Director of Public
More informationRural Health Policy and. Internship Forum. An Overview of Rural Health Policy Marcia K. Brand, Ph.D. Shepherd University, April 28, 2017
Rural Health Policy and 1 Internship Forum An Overview of Rural Health Policy Marcia K. Brand, Ph.D. Shepherd University, April 28, 2017 2 This Presentation What is rural? Rural vs. urban how are they
More informationREFERENCE CODE GDHC317DFR PUBLICAT ION DATE DECEMBER 2013 LUCENTIS (MICROVASCULAR COMPLICATIONS OF DIABETES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC317DFR PUBLICAT ION DATE DECEMBER 2013 LUCENTIS Executive Summary The table below presents a summary of the key metrics for Lucentis (Microvascular Complications for Diabetes) for recombinant
More informationCritical Care. Building Future Growth with Innovation. Katie M. Szyman Corporate Vice President, Critical Care
Katie M. Szyman Corporate Vice President, Building Future Growth with Innovation Products Benefit Millions of Patients per Year Our new HemoSphere capital platform strengthens our core portfolio We are
More informationGlobal Invisible Braces Market: Trends, Opportunities and Forecasts ( )
Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,
More informationPATIENT VIEWS (PART 1 OF A 3-PART SERIES)
(PART 1 OF A 3-PART SERIES) powered by: The physician: America s most trusted OTC adviser TREATMENT SOUGHT BY CONDITION IN THE PAST 12 MONTHS 81% 31% Allergy (n=662) 11% 80% Cough-cold-flu (n=664) Source:
More information2015 Annual Convention
2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 8:00 am 9:30 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 2 Title: Activity Type: Speaker: Benefit from
More informationDARA Reports Year-End 2012 Financial Results
April 1, 2013 DARA Reports Year-End 2012 Financial Results Company Provides a Commercial Portfolio and Development Pipeline Business Update RALEIGH, NC -- (MARKETWIRE) -- 04/01/13 -- DARA BioSciences,
More informationWide variations in both spending
Hospital Quality And Intensity Of Spending: Is There An Association? Hospitals performance on quality of care is not associated with the intensity of their spending. by Laura Yasaitis, Elliott S. Fisher,
More informationData-Driven Study Feasibility Assessment and Impact on Successful Execution of Clinical Trial Protocols
Data-Driven Study Feasibility Assessment and Impact on Successful Execution of Clinical Trial Protocols Bill Gwinn Vice-President Clinical Informatics Solutions Optum DIA Session: Next Generation Feasibility:
More informationMArch The 2014 Drug Trend Report Highlights
MArch 2015 The 2014 Drug Report Highlights Highest Increase in U.S. Drug Spend Over Past Decade In 2014, the pharmacy landscape underwent a seismic change, and the budgetary impact to healthcare payers
More informationChapter 6: Healthcare Expenditures for Persons with CKD
Chapter 6: Healthcare Expenditures for Persons with CKD In this 2017 Annual Data Report (ADR), we introduce information from the Optum Clinformatics DataMart for persons with Medicare Advantage and commercial
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Shire plc January 10, 2012 Angus Russell Chief Executive Officer Our purpose We enable people with life-altering conditions to lead better lives. THE SAFE HARBOR STATEMENT
More informationItamar Medical. December Investors Presentation.
Itamar Medical December 2017. Investors Presentation. Disclaimer Itamar Medical Ltd. (the "Company") is furnishing this presentation and any information given during this presentation, solely for the consideration
More informationImpact of Eliminating Medicaid Adult Dental Coverage in California on Emergency. Department Use for Dental Problems
Impact of Eliminating Medicaid Adult Dental Coverage in California on Emergency Department Use for Dental Problems Introduction: Oral health is an integral part of overall well-being. Apart from having
More informationREFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA US DRUG FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA Executive Summary Schizophrenia Sales in the US, 2012 The combined sales of medications carrying an indication in schizophrenia in
More informationREFERENCE CODE GDHC1087DFR PUBLICATION DATE JUNE 2013
REFERENCE CODE GDHC1087DFR PUBLICATION DATE JUNE 2013 Executive Summary Diovan (valsartan): Key Metrics in the Seven Major Pharmaceutical Markets* 2012 Market Sales US - Diovan 5EU - Diovan Japan - Diovan
More informationBank of America Chicago Marathon Sunday, October 9, Corporate Sponsorship Opportunities
Bank of America Chicago Marathon Sunday, October 9, 2011 2011 Corporate Sponsorship Opportunities Children s Memorial Hospital is the only freestanding acute care hospital in Illinois devoted exclusively
More informationADM to Acquire Neovia and Probiotics International Limited. July 2, 2018
ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates
More informationGN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008
GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord A/S GN GN Store Store Nord Nord Listed Listed company
More informationHear better, Live fully.
EPIC Hearing Healthcare 3191 W. Temple Ave Suite 200 Pomona, CA 91768 Corporate Toll Free: 877.606.3742 Email: sales@epichearing.com www.epichearing.com Hear better, Live fully. ASO-2013 ASO Savings Plan
More informationStudy Links Use of Intraoperative Neuromonitoring during Spine Surgery to Improved Outcomes, Lower Opioid Use
SpecialtyCare Insight Study Links Use of Intraoperative Neuromonitoring during Spine Surgery to Improved Outcomes, Lower Opioid Use INSIGHT Spine surgery is a commonly performed procedure today, but even
More informationtaking at (Jan. 21, 2016) by Older 2016.pdf).
HSGAC MINORITY STAFF REPORT MANUFACTURED CRISIS How Devastating Drug Increases Are Harming America s Seniors U.S. Senate Homeland Security & Governmental Affairs Committee, Minority Office Page 1 EXECUTIVE
More informationCounty of Sacramento. Review of Population Health through Kaiser Permanente Data
County of Sacramento Review of Population Health through Kaiser Permanente Data Dr. Diane Dailey, M.D., Chief of Business Health Engagement Eileen Peterson, MPH, RD, TPMG Business Health Consultant, Public
More informationSlide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes
Slide 1 International Operations update Mike Doustdar EVP International Operations YASMIN FIEDLER, Germany Yasmin has type 1 diabetes Slide 2 Forward-looking statements Novo Nordisk s reports filed with
More informationAcross The Chasm: The Transition From Volume To Value
Across The Chasm: The Transition From Volume To Value Joseph Bisordi, MD, Executive Vice President & CMO Ochsner Health System Our Mission is to Serve, Heal, Lead, Educate, and Innovate $1.6 Revenue ($B)
More information36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018
36th Annual J.P. Morgan Healthcare Conference Kevin Conroy, Chairman and CEO January 9, 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section
More informationREFERENCE CODE GDHCER022 PUBLICAT ION DATE AUGUST 2013 OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
REFERENCE CODE GDHCER022 PUBLICAT ION DATE AUGUST 2013 OVERWEIGHT AND OBESITY - Executive Summary Obesity is an escalating global public health problem that has reached pandemic proportions. It is caused
More informationUS pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
More informationDiagnostics for the early detection and prevention of colon cancer. Leerink Swann Global Health Care Conference February 2015
Diagnostics for the early detection and prevention of colon cancer Leerink Swann Global Health Care Conference February 2015 Safe Harbor Statement Certain statements made in this news release contain forward-looking
More informationFORM8-K HILLENBRAND,INC.
UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934 Date of Report (Date of earliest event reported): December18,2015
More informationBest Doctors Service Card. Connecting Canadians to the world s best medical information
Best Doctors Service Card Connecting Canadians to the world s best medical information If the worst happens, help is only a phone call away Having the best medical knowledge for any important healthcare
More informationMexico Ostomy Drainage Bags Market Outlook to 2020
Mexico Ostomy Drainage Bags Market Outlook to 2020 Reference Code: GDMECC0990DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...
More informationLauren Silvernail, CFO & VP Corporate Development to present at 2005 Thomas Weisel Partners Healthcare Conference on September 7, 2005 at 3:50 pm EST
Lauren Silvernail, CFO & VP Corporate Development to present at 2005 Thomas Weisel Partners Healthcare Conference on September 7, 2005 at 3:50 pm EST Forward Looking Statements Certain statements contained
More informationFood Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS
Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s future
More information